Phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) is an AMPK target participating in contraction-stimulated glucose uptake in skeletal muscle

Biochemical Journal

Volumn 455, Issue 2, 2013, Pages 195-206

  Liu, Yang ^a   Lai, Yu Chiang ^a   Hill, Elaine V ^b   Tyteca, Donatienne ^a   Carpentier, Sarah ^a   Ingvaldsen, Ada ^c   Vertommen, Didier ^a   Lantier, Louise ^d,e   Foretz, Marc ^d,e   Dequiedt, Franck ^f   Courtoy, Pierre J ^a   Erneux, Christophe ^g   Viollet, Benoit ^d,e   Shepherd, Peter R ^h   Tavare, Jeremy M ^b   Jensen, Jørgen ^c   Rider, Mark H ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^d INSTITUT COCHIN   (France)

^e CNRS   (France)

^f UNIVERSITY OF LIÈGE   (Belgium)

^g UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^h UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

AMP activated protein kinase (AMPK); Contraction; Glucose uptake; Insulin; Protein kinase B (PKB); PtdIns(3,5)P2

Indexed keywords

ADENYLATE KINASE; GLUCOSE TRANSPORTER 4; PHOSPHATIDYLINOSITOL 3 PHOSPHATE; PHOSPHATIDYLINOSITOL 3 PHOSPHATE 5 KINASE; PHOSPHOTRANSFERASE INHIBITOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; YM 201636;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENDOSOME; ENZYME ACTIVATION; GLUCOSE TRANSPORT; IN VITRO STUDY; INTRACELLULAR MEMBRANE; KIDNEY CELL; MOUSE; MUSCLE CONTRACTION; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; SKELETAL MUSCLE;

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; MALE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; OPOSSUMS; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHORYLATION; RATS; RATS, WISTAR;

EID: 84884742734     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20130644     Document Type: Article

References (52)

1. Huang, S. and Czech, M. P. (2007) The GLUT4 glucose transporter. Cell Metab. 5, 237-252
2. Sano, H., Kane, S., Sano, E., Miinea, C. P., Asara, J. M., Lane, W. S., Garner, C. W. and Lienhard, G. E. (2003) Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J. Biol. Chem. 278, 14599-14602
3. Roach, W. G., Chavez, J. A., Miinea, C. P. and Lienhard, G. E. (2007) Substrate specificity and effect on GLUT4 translocation of the Rab GTPase-activating protein Tbc1d1. Biochem. J. 403, 353-358
4. Sakamoto, K. and Holman, G. D. (2008) Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic. Am. J. Physiol. Endocrinol. Metab. 295, E29-E37
5. Sbrissa, D., Ikonomov, O. C. and Shisheva, A. (1999) PIKfyve, a mammalian ortholog of yeast Fab1p lipid kinase, synthesizes 5-phosphoinositides. Effect of insulin. J. Biol. Chem. 274, 21589-21597
6. Shisheva, A. (2008) PIKfyve: partners, significance, debates and paradoxes. Cell Biol. Int. 32, 591-604
7. Shisheva, A., Rusin, B., Ikonomov, O. C., DeMarco, C. and Sbrissa, D. (2001) Localization and insulin-regulated relocation of phosphoinositide 5-kinase PIKfyve in 3T3-L1 adipocytes. J. Biol. Chem. 276, 11859-11869
8. Ikonomov, O. C., Sbrissa, D. and Shisheva, A. (2001) Mammalian cell morphology and endocytic membrane homeostasis require enzymatically active phosphoinositide 5-kinase PIKfyve. J. Biol. Chem. 276, 26141-26147
9. Rutherford, A. C., Traer, C., Wassmer, T., Pattni, K., Bujny, M. V., Carlton, J. G., Stenmark, H. and Cullen, P. J. (2006) The mammalian phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) regulates endosome-to-TGN retrograde transport. J. Cell Sci. 119, 3944-3957
10. Ikonomov, O. C., Sbrissa, D., Mlak, K., Kanzaki, M., Pessin, J. and Shisheva, A. (2002) Functional dissection of lipid and protein kinase signals of PIKfyve reveals the role of PtdIns 3,5-P2 production for endomembrane integrity. J. Biol. Chem. 277, 9206-9211
11. Jefferies, H. B., Cooke, F. T., Jat, P., Boucheron, C., Koizumi, T., Hayakawa, M., Kaizawa, H., Ohishi, T., Workman, P., Waterfield, M. D. and Parker, P. J. (2008) A selective PIKfyve inhibitor blocks PtdIns(3,5)P2 production and disrupts endomembrane transport and retroviral budding. EMBO Rep. 9, 164-170
12. Ikonomov, O. C., Sbrissa, D., Ijuin, T., Takenawa, T. and Shisheva, A. (2009) Sac3 is an insulin-regulated phosphatidylinositol 3,5-bisphosphate phosphatase: gain in insulin responsiveness through Sac3 down-regulation in adipocytes. J. Biol. Chem. 284, 23961-23971
13. Bridges, D., Ma, J. T., Park, S., Inoki, K., Weisman, L. S. and Saltiel, A. R. (2012) Phosphatidylinositol 3,5-bisphosphate plays a role in the activation and subcellular localization of mechanistic target of rapamycin 1. Mol. Biol. Cell 23, 2955-2962
14. Ikonomov, O. C., Sbrissa, D., Dondapati, R. and Shisheva, A. (2007) ArPIKfyve-PIKfyve interaction and role in insulin-regulated GLUT4 translocation and glucose transport in 3T3-L1 adipocytes. Exp. Cell Res. 313, 2404-2416
15. Ikonomov, O. C., Sbrissa, D. and Shisheva, A. (2009) YM201636, an inhibitor of retroviral budding and PIKfyve-catalyzed PtdIns(3,5)P2 synthesis, halts glucose entry by insulin in adipocytes. Biochem. Biophys. Res. Commun. 382, 566-570
16. Berwick, D. C., Dell, G. C., Welsh, G. I., Heesom, K. J., Hers, I., Fletcher, L. M., Cooke, F. T. and Tavare, J. M. (2004) Protein kinase B phosphorylation of PIKfyve regulates the trafficking of GLUT4 vesicles. J. Cell Sci. 117, 5985-5993
17. Leney, S. E. and Tavare, J. M. (2009) The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and potential drug targets. J. Endocrinol. 203, 1-18
18. Jensen, T. E., Wojtaszewski, J. F. and Richter, E. A. (2009) AMP-activated protein kinase in contraction regulation of skeletal muscle metabolism: necessary and/or sufficient? Acta Physiol. 196, 155-174
19. Richter, E. A. and Ruderman, N. B. (2009) AMPK and the biochemistry of exercise: implications for human health and disease. Biochem. J. 418, 261-275
20. Lefort, N., St-Amand, E., Morasse, S., Cote, C. H. and Marette, A. (2008) The ?-subunit of AMPK is essential for submaximal contraction-mediated glucose transport in skeletal muscle in vitro. Am. J. Physiol. Endocrinol. Metab. 295, E1447-E1454
21. Lee-Young, R. S., Griffee, S. R., Lynes, S. E., Bracy, D. P., Ayala, J. E., McGuinness, O. P. and Wasserman, D. H. (2009) Skeletal muscle AMP-activated protein kinase is essential for the metabolic response to exercise in vivo. J. Biol. Chem. 284, 23925-23934
22. O'Neill, H. M., Maarbjerg, S. J., Crane, J. D., Jeppesen, J., Jorgensen, S. B., Schertzer, J. D., Shyroka, O., Kiens, B., van Denderen, B. J., Tarnopolsky, M. A. et al. (2011) AMP-activated protein kinase (AMPK) ?1?2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc. Natl. Acad. Sci. U.S.A. 108, 16092-16097
23. Kramer, H. F., Witczak, C. A., Taylor, E. B., Fujii, N., Hirshman, M. F. and Goodyear, L. J. (2006) AS160 regulates insulin-and contraction-stimulated glucose uptake in mouse skeletal muscle. J. Biol. Chem. 281, 31478-31485
24. Bruss, M. D., Arias, E. B., Lienhard, G. E. and Cartee, G. D. (2005) Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity. Diabetes 54, 41-50
25. An, D., Toyoda, T., Taylor, E. B., Yu, H., Fujii, N., Hirshman, M. F. and Goodyear, L. J. (2010) TBC1D1 regulates insulin-and contraction-induced glucose transport in mouse skeletal muscle. Diabetes 59, 1358-1365
26. Lai, Y. C., Liu, Y., Jacobs, R. and Rider, M. H. (2012) A novel PKB/Akt inhibitor, MK-2206, effectively inhibits insulin-stimulated glucose metabolism and protein synthesis in isolated rat skeletal muscle. Biochem. J. 447, 137-147
27. Horman, S., Morel, N., Vertommen, D., Hussain, N., Neumann, D., Beauloye, C., El Najjar, N., Forcet, C., Viollet, B., Walsh, M. P. et al. (2008) AMP-activated protein kinase phosphorylates and desensitizes smooth muscle myosin light chain kinase. J. Biol. Chem. 283, 18505-18512
28. Hill, E. V., Hudson, C. A., Vertommen, D., Rider, M. H. and Tavare, J. M. (2010) Regulation of PIKfyve phosphorylation by insulin and osmotic stress. Biochem. Biophys. Res. Commun. 397, 650-655
29. Mouton, V., Toussaint, L., Vertommen, D., Gueuning, M. A., Maisin, L., Havaux, X., Sanchez-Canedo, C., Bertrand, L., Dequiedt, F., Hemmings, B. A. et al. (2010) Heart 6-phosphofructo-2-kinase activation by insulin requires PKB (protein kinase B), but not SGK3 (serum-and glucocorticoid-induced protein kinase 3). Biochem. J. 431, 267-275
30. Dale, S., Wilson, W. A., Edelman, A. M. and Hardie, D. G. (1995) Similar substrate recognition motifs for mammalian AMP-activated protein kinase, higher plant HMG-CoA reductase kinase-A, yeast SNF1, and mammalian calmodulin-dependent protein kinase I. FEBS Lett. 361, 191-195
31. Aslesen, R., Engebretsen, E. M., Franch, J. and Jensen, J. (2001) Glucose uptake and metabolic stress in rat muscles stimulated electrically with different protocols. J. Appl. Physiol. 91, 1237-1244
32. Zarrinpashneh, E., Carjaval, K., Beauloye, C., Ginion, A., Mateo, P., Pouleur, A. C., Horman, S., Vaulont, S., Hoerter, J., Viollet, B. et al. (2006) Role of the ?2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia. Am. J. Physiol. Heart Circ. Physiol. 291, H2875-H2883
33. Funai, K. and Cartee, G. D. (2009) Inhibition of contraction-stimulated AMP-activated protein kinase inhibits contraction-stimulated increases in PAS-TBC1D1 and glucose transport without altering PAS-AS160 in rat skeletal muscle. Diabetes 58, 1096-1104
34. Schwenk, R. W., Dirkx, E., Coumans, W. A., Bonen, A., Klip, A., Glatz, J. F. and Luiken, J. J. (2010) Requirement for distinct vesicle-associated membrane proteins in insulinand AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes. Diabetologia 53, 2209-2219
35. Lantier, L., Mounier, R., Leclerc, J., Pende, M., Foretz, M. and Viollet, B. (2010) Coordinated maintenance of muscle cell size control by AMP-activated protein kinase. FASEB J. 24, 3555-3561
36. Lai, Y. C., Zarrinpashneh, E. and Jensen, J. (2010) Additive effect of contraction and insulin on glucose uptake and glycogen synthase in muscle with different glycogen contents. J. Appl. Physiol. 108, 1106-1115
37. de Lartigue, J., Polson, H., Feldman, M., Shokat, K., Tooze, S. A., Urbe, S. and Clague, M. J. (2009) PIKfyve regulation of endosome-linked pathways. Traffic 10, 883-893
38. Lai, Y. C., Stuenaes, J. T., Kuo, C. H. and Jensen, J. (2007) Glycogen content and contraction regulate glycogen synthase phosphorylation and affinity for UDP-glucose in rat skeletal muscles. Am. J. Physiol. Endocrinol. Metab. 293, E1622-E1629
39. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254
40. Horman, S., Browne, G., Krause, U., Patel, J., Vertommen, D., Bertrand, L., Lavoinne, A., Hue, L., Proud, C. and Rider, M. (2002) Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr. Biol. 12, 1419-1423
41. Merrill, G. F., Kurth, E. J., Hardie, D. G. and Winder, W. W. (1997) AICAriboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. Endocrinol. Metab. 273, E1107-E1112
42. Barnes, B. R., Marklund, S., Steiler, T. L., Walter, M., Hjalm, G., Amarger, V., Mahlapuu, M., Leng, Y., Johansson, C., Galuska, D. et al. (2004) The 5-AMP-activated protein kinase ? 3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J. Biol. Chem. 279, 38441-38447
43. Jorgensen, S. B., Viollet, B., Andreelli, F., Frosig, C., Birk, J. B., Schjerling, P., Vaulont, S., Richter, E. A. and Wojtaszewski, J. F. (2004) Knockout of the ?2 but not ?1 5-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-?-4-ribofuranoside but not contraction-induced glucose uptake in skeletal muscle. J. Biol. Chem. 279, 1070-1079
44. Touchberry, C. D., Bales, I. K., Stone, J. K., Rohrberg, T. J., Parelkar, N. K., Nguyen, T., Fuentes, O., Liu, X., Qu, C. K., Andresen, J. J. et al. (2010) Phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) potentiates cardiac contractility via activation of the ryanodine receptor. J. Biol. Chem. 285, 40312-40321
45. Liu, Y., Vertommen, D., Rider, M. H. and Lai, Y. C. (2013) Mammalian target of rapamycin-independent S6K1 and 4E-BP1 phosphorylation during contraction in rat skeletal muscle. Cell. Signalling 25, 1877-1886
46. Knight, Z. A., Feldman, M. E., Balla, A., Balla, T. and Shokat, K. M. (2007) A membrane capture assay for lipid kinase activity. Nat. Protoc. 2, 2459-2466
47. Shen, J., Yu, W. M., Brotto, M., Scherman, J. A., Guo, C., Stoddard, C., Nosek, T. M., Valdivia, H. H. and Qu, C. K. (2009) Deficiency of MIP/MTMR14 phosphatase induces a muscle disorder by disrupting Ca2+ homeostasis. Nat. Cell Biol. 11, 769-776
48. Zolov, S. N., Bridges, D., Zhang, Y., Lee, W. W., Riehle, E., Verma, R., Lenk, G. M., Converso-Baran, K., Weide, T., Albin, R. L. et al. (2012) In vivo, Pikfyve generates PI(3,5)P2, which serves as both a signaling lipid and the major precursor for PI5P. Proc. Natl. Acad. Sci. U.S.A. 109, 17472-17477
49. Kramer, H. F., Witczak, C. A., Fujii, N., Jessen, N., Taylor, E. B., Arnolds, D. E., Sakamoto, K., Hirshman, M. F. and Goodyear, L. J. (2006) Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. Diabetes 55, 2067-2076
50. Marsin, A. S., Bertrand, L., Rider, M. H., Deprez, J., Beauloye, C., Vincent, M. F., Van den Berghe, G., Carling, D. and Hue, L. (2000) Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr. Biol. 10, 1247-1255
51. Chen, Z. P., Mitchelhill, K. I., Michell, B. J., Stapleton, D., Rodriguez-Crespo, I., Witters, L. A., Power, D. A., Ortiz de Montellano, P. R. and Kemp, B. E. (1999) AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett. 443, 285-289
52. Ducommun, S., Wang, H. Y., Sakamoto, K., MacKintosh, C. and Chen, S. (2012) Thr649Ala-AS160 knock-in mutation does not impair contraction/AICAR- induced glucose transport in mouse muscle. Am. J. Physiol. Endocrinol. Metab. 302, E1036-E1043